NIH-funded research R01 grant

Protecting newborn brains in babies born with transposition of the great arteries

Official title: The Risk of Acquired Neonatal Significant brain Injury during perinatal Transition in Congenital Heart Disease: TRANSIT CHD study

Funded at University of California, San Francisco · NIH-11306049 · Data updated 2026-11-12

Doctors will follow babies with transposition of the great arteries from pregnancy through birth to find early signs and ways to protect their brains during the newborn transition.

More Brain Injury research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startMay 1, 2022
Project endFebruary 28, 2027
Funding year2026
Award (this year)$435,857
NIH project number5R01NS125404-05
Project IDNIH-11306049 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people whose fetus has been diagnosed with TGA or a similar critical congenital heart defect and who can receive prenatal care and deliver at the participating hospitals are the ideal candidates.

Less likely to help

People without congenital heart disease, newborns beyond the immediate perinatal period, or families who cannot receive care at a participating center are unlikely to receive direct benefit from this project.

What this research studies

If your fetus is diagnosed with transposition of the great arteries (TGA), the team will follow you from late pregnancy through the newborn period using fetal imaging and neonatal brain monitoring. They will measure how blood flow and oxygen delivery change during the transition from fetal to newborn circulation, perform brain MRIs and neuromonitoring before surgery, and collect clinical data and samples to look for early markers of white matter injury. The goal is to link specific perinatal physiologic changes to brain injury risk and to identify care practices that might reduce that risk, such as timing of cord clamping. Participation would be coordinated with your clinical care and requires consent for imaging and monitoring procedures that are standard or low-risk in this setting.

Why it matters

Potential benefit: If successful, this work could identify early markers and practical care changes that reduce newborn white matter injury and improve long-term brain development for children with TGA.

How similar studies have gone: Some prior work (for example on delayed cord clamping) has shown neuroprotective effects in newborns, but following fetuses with TGA from pregnancy through birth to find prenatal biomarkers of brain injury is a relatively new approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Peyvandi, Shabnam — University of California, San Francisco
  • Study coordinator: Peyvandi, Shabnam

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.